Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Unlocking the power of tryptamine alkaloids in Psilocybe fungi: chemistry, mental health potential and legal challenges

Mohammad Reza Mirzadeh, Khalid Moinuddin, Vasso Apostolopoulos, Caine Barlow, Jianhua Zhang

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (107)

  1. The Australia story: Current status and future challenges for the clinical applications of psychedelics. 2026-07-01 · Expand citations
  2. Development of Psilocybe Mushroom Species Reference Material-Cultivation Parameters and Chemical Profiles. 2026-01-01 · Expand citations
  3. Exploring the Frontiers of Psychedelics: A New Chromatographic Method for Detection and Quantification of Psilocybin and Psilocin in Psilocybe cubensis Mushrooms 2025-07-22 · Expand citations
  4. Insights into therapeutic potential and practical applications of natural toxins from poisonous mushrooms. 2025-01-01 · Expand citations
  5. Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trial. 2025-01-01 · Expand citations
  6. Psilocybin: revealing the enigmas of a revolutionary fungi 2025-01-01 · Expand citations
  7. Legal and Ethics Concerns of Psilocybin as Medicine. 2024-12-12 · Expand citations
  8. Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushrooms. 2024-10-01 · Expand citations
  9. A taxonomy of regulatory and policy matters relevant to psychedelic-assisted therapy in Australia. 2024-07-01 · Expand citations
  10. Methyl transfer in psilocybin biosynthesis. 2024-03-28 · Expand citations
  11. Psychedelics and sexual functioning: a mixed-methods study. 2024-02-07 · Expand citations
  12. Determination of psilocybin and psilocin content in multiple Psilocybe cubensis mushroom strains using liquid chromatography - tandem mass spectrometry 2024-02-01 · Expand citations
  13. Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin 2024-01-06 · Expand citations
  14. Alterations in brain network connectivity and subjective experience induced by psychedelics: a scoping review. 2024-01-01 · Expand citations
  15. A journey with psychedelic mushrooms: From historical relevance to biology, cultivation, medicinal uses, biotechnology, and beyond. 2023-12-01 · Expand citations
  16. The evolution and ecology of psilocybin in nature. 2023-06-01 · Expand citations
  17. A review of psilocybin: chemistry, clinical uses and future research directions 2023-05-16 · Expand citations
  18. Genome sequencing progenies of magic mushrooms (Psilocybe subaeruginosa) identifies tetrapolar mating and gene duplications in the psilocybin pathway. 2023-03-01 · Expand citations
  19. Psychedelic Drug Legislative Reform and Legalization in the US. 2023-01-01 · Expand citations
  20. From prohibited to prescribed: The rescheduling of MDMA and psilocybin in Australia 2022-12-31 · Expand citations
  21. DNA Authentication and Chemical Analysis of Mushrooms Reveal Widespread Misdeterminations in Fungaria and Inconsistencies in Metabolites. 2022-12-20 · Expand citations
  22. Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids. 2022-11-15 · Expand citations
  23. Optimization through a Box-Behnken Experimental Design of the Microwave-Assisted Extraction of the Psychoactive Compounds in Hallucinogenic Fungi (). 2022-06-02 · Expand citations
  24. Evaluation of a quantitative analytical method for psilocin and psilocybin using HPLC-DAD 2022-04-06 · Expand citations
  25. Diversity, biology, and history of psilocybin-containing fungi: Suggestions for research and technological development. 2022-04-01 · Expand citations
  26. Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression. 2022-01-01 · Expand citations
  27. The Therapeutic Potential of Psilocybin. 2021-05-15 · Expand citations
  28. Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensis. 2021-02-01 · Expand citations
  29. Simultaneous Production of Psilocybin and a Cocktail of β-Carboline Monoamine Oxidase Inhibitors in "Magic" Mushrooms. 2020-01-13 · Expand citations
  30. The Psilocybin-Telomere Hypothesis: An empirically falsifiable prediction concerning the beneficial neuropsychopharmacological effects of psilocybin on genetic aging. 2020-01-01 · Expand citations
  31. Injury-Triggered Blueing Reactions of Psilocybe “Magic” Mushrooms 2019-11-14 · Expand citations
  32. Unpredictable Behavior Under the Influence of "Magic Mushrooms": A Case Report and Review of the Literature. 2019-07-01 · Expand citations
  33. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels 2019-06-01 · Expand citations
  34. Modeling Retention Behavior on Analysis of Hallucinogenic Mushrooms Using Hydrophilic Interaction Liquid Chromatography. 2019-03-01 · Expand citations
  35. Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults. 2017-12-01 · Expand citations
  36. Enzymatic Synthesis of Psilocybin. 2017-09-25 · Expand citations
  37. Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance 2017-01-02 · Expand citations
  38. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. 2016-12-01 · Expand citations
  39. HPLC Analysis of Hallucinogenic Mushroom Alkaloids (Psilocin and Psilocybin) Applying Hydrophilic Interaction Chromatography (HILIC) 2016-01-01 · Expand citations
  40. Recreational use, analysis and toxicity of tryptamines. 2015-01-01 · Expand citations
  41. Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. 2014-11-01 · Expand citations
  42. Psilocybin--summary of knowledge and new perspectives. 2014-03-01 · Expand citations
  43. Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction. 2014-01-01 · Expand citations
  44. Fungal Hallucinogens Psilocin, Ibotenic Acid, and Muscimol 2013-08-01 · Expand citations
  45. A validated method for quantitation of psilocin in plasma by LC-MS/MS and study of stability 2012-11-01 · Expand citations
  46. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. 2012-02-07 · Expand citations
  47. Enhancement of Indole Alkaloids Produced by Psilocybe cubensis (Earle) Singer (Agaricomycetideae) in Controlled Harvesting Light Conditions 2009-01-01 · Expand citations
  48. The Determination of Psilocin and Psilocybin in Hallucinogenic Mushrooms by HPLC Utilizing a Dual Reagent Acidic Potassium Permanganate and Tris(2,2′-bipyridyl)ruthenium(II) Chemiluminescence Detection System 2006-01-01 · Expand citations
  49. Determination of psilocybin in hallucinogenic mushrooms by reversed-phase liquid chromatography with fluorescence detection. 2005-04-30 · Expand citations
  50. Morphological and chemical analysis of magic mushrooms in Japan. 2003-12-17 · Expand citations
  51. The pharmacology of psilocybin. 2002-10-01 · Expand citations
  52. Hallucinogenic mushrooms on the German market - simple instructions for examination and identification. 2000-09-11 · Expand citations
  53. Analysis of psilocybin and psilocin in Psilocybe subcubensis GUZMÁN by ion mobility spectrometry and gas chromatography-mass spectrometry 1999-01-01 · Expand citations
  54. Strategies for the capillary electrophoretic separation of indole alkaloids in Psilocybe semilanceata. 1998-01-01 · Expand citations
  55. Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man 1997-06-01 · Expand citations
  56. Ethnomycology, biochemistry, and cultivation of Psilocybe samuiensis Guzmán, Bandala and Allen, a new psychoactive fungus from Koh Samui, Thailand. 1994-07-08 · Expand citations
  57. Extraction and analysis of indole derivatives from fungal biomass. 1994-01-01 · Expand citations
  58. An Aqueous-Organic Extraction Method for the Isolation and Identification of Psilocin from Hallucinogenic Mushrooms 1985-01-01 · Expand citations
  59. Analysis of indole alkaloids in Norwegian Psilocybe semilanceata using high-performance liquid chromatography and mass spectrometry 1982-07-01 · Expand citations
  60. Variation of psilocybin and psilocin levels with repeated flushes (harvests) of mature sporocarps of Psilocybe cubensis (earle) singer 1982-05-01 · Expand citations
  61. Comparison of solution conformational preferences for the hallucinogens bufotenin and psilocin using 360-MHz proton NMR spectroscopy 1981-02-01 · Expand citations
  62. The Psilocybin Mushroom Pandemic 1975-01-01 · Expand citations
  63. The occurrence of the psychotomimetic agent psilocybin in an Australian agaric, Psilocybe subaeruginosa 1970-04-01 · Expand citations
  64. Dephosphorylation of psilocybin in the intact mouse. 1962-11-01 · Expand citations
  65. OpenAlex W1528809860
  66. OpenAlex W1897916411
  67. OpenAlex W1987854012
  68. OpenAlex W1992988465
  69. OpenAlex W2002070445
  70. OpenAlex W2028455253
  71. OpenAlex W2048213004
  72. OpenAlex W2065164655
  73. OpenAlex W2067074477
  74. OpenAlex W2081244857
  75. OpenAlex W2109129280
  76. OpenAlex W2151299278
  77. OpenAlex W2344174142
  78. OpenAlex W2477064963
  79. OpenAlex W2505902013
  80. OpenAlex W2523448007
  81. OpenAlex W2531441702
  82. OpenAlex W2753941774
  83. OpenAlex W2901367898
  84. OpenAlex W2903629062
  85. OpenAlex W2996555671
  86. OpenAlex W3012132035
  87. OpenAlex W3037166788
  88. OpenAlex W3203764376
  89. OpenAlex W3204569170
  90. OpenAlex W4211249082
  91. OpenAlex W4230167918
  92. OpenAlex W4241015801
  93. OpenAlex W4247466629
  94. OpenAlex W4287009339
  95. OpenAlex W4319298186
  96. OpenAlex W4321033185
  97. OpenAlex W4386765415
  98. OpenAlex W4388302270
  99. OpenAlex W4393993168
  100. OpenAlex W4400929013
  101. OpenAlex W4401711366
  102. OpenAlex W4402462242
  103. OpenAlex W4405955628
  104. OpenAlex W4410645269
  105. OpenAlex W4411116696
  106. OpenAlex W561083445
  107. OpenAlex W576303774

Cited by — these papers cite this paper (0)

No citing papers identified in the available metadata. This does not establish that none exist.